E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (SECURE)
SECURE - A poSt-market Registry in Patients With infrarEnal aortiC Aneurysm Undergoing endovasculaR Stenting With the New E-tegra Stent Graft System
Sponsor: JOTEC GmbH
Terminated
Due to product change.
Other terminated trials from JOTEC GmbH
More terminations from JOTEC GmbH
Other AAA trials with similar outcome
Listed as NCT02485496, this observational or N/A phase trial focuses on AAA and Abdominal Aortic Aneurysm and remains terminated or withdrawn. Sponsored by JOTEC GmbH, it has been updated 12 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jun 2022 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
May 2022 — Jun 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Mar 2021 — May 2022 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
May 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — May 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- JOTEC GmbH
For direct contact, visit the study record on ClinicalTrials.gov .